下一代定序資訊學市場－全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品與服務、應用、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球次世代定序 (NGS) 資訊學市場價值 54.8 億美元，預計到 2030 年將達到 187.4 億美元，複合年成長率為 22.74%。由於癌症發病率的上升和 NGS 臨床應用的不斷擴大，市場正在經歷大幅成長。 2020 年，全球癌症觀察站記錄了超過 1,900 萬例新發癌症病例，其中最常見的是乳癌、肺癌、大腸癌、攝護腺癌和胃癌。 DNA 定序樣本數量的增加、定序成本的下降、政府支持的基因組計劃以及 NGS 相對於傳統微陣列技術的日益普及，都促進了市場擴張。隨著定序變得更加經濟實惠且成為疾病診斷和治療不可或缺的一部分，對能夠管理、分析和解釋大規模基因組資料的強大資訊學平台的需求持續成長。

關鍵市場促進因素

精準醫療和基因組診斷的應用日益普及

主要市場趨勢

人工智慧和機器學習在NGS資訊學中的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球下一代定序（NGS）資訊學市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按產品和服務（儲存和計算工具、商業數據分析、數據解釋和報告工具、下一代定序 (NGS) 資訊學服務、實驗室資訊管理系統 (LIMS)）
  • 按應用（藥物發現、基因篩檢、疾病診斷等）
  • 按最終用戶（醫院和診斷中心、製藥和生物技術公司、學術和研究機構）
  • 按地區（北美、歐洲、亞太、南美、中東和非洲）
  • 按公司分類（2024）
• 市場地圖
  • 按產品和服務
  • 按應用
  • 按最終用戶
  • 按地區

第6章：北美次世代定序（NGS）資訊學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲次世代定序（NGS）資訊學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區次世代定序（NGS）資訊學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲

第9章：南美下一代定序（NGS）資訊學市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲下一代定序 (NGS) 資訊學市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品/服務的威脅

第 14 章：全球下一代定序 (NGS) 資訊學市場：SWOT 分析

第 15 章：競爭格局

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN NV
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

第 16 章：策略建議

第17章調查會社について,免責事項

The Global Next Generation Sequencing (NGS) Informatics Market was valued at USD 5.48 billion in 2024 and is projected to reach USD 18.74 billion by 2030, growing at a CAGR of 22.74%. The market is witnessing substantial growth due to the increasing incidence of cancer and expanding clinical applications of NGS. In 2020, the Global Cancer Observatory recorded over 19 million new cancer cases, with breast, lung, colorectal, prostate, and stomach cancers being the most common. Contributing to market expansion are the rising number of DNA sequencing samples, declining sequencing costs, government-backed genomic initiatives, and growing adoption of NGS over traditional microarray technologies. As sequencing becomes more affordable and integral to disease diagnosis and treatment, the demand for robust informatics platforms capable of managing, analyzing, and interpreting large-scale genomic data continues to grow.

Key Market Drivers

Rising Adoption of Precision Medicine and Genomic-Based Diagnostics

The widespread integration of precision medicine and genomic diagnostics into clinical workflows is a key driver of the NGS informatics market. By enabling the analysis of entire genetic profiles, NGS facilitates identification of disease-causing mutations and supports individualized treatment strategies. Government-led initiatives such as the NIH's "All of Us Research Program" reflect this trend, collecting genetic data from over one million participants-over 600,000 of whom had enrolled by 2023. This surge in data fuels the demand for informatics platforms that can store, process, and interpret high-throughput sequencing information. Additionally, broader insurance coverage for genomic testing in countries like the United States is encouraging greater adoption of NGS technologies in hospitals and clinical labs. According to CMS, spending on NGS-based tests has significantly increased, underlining the growing clinical importance of these tools. As a result, demand for scalable NGS informatics systems that can automate variant analysis and support clinical decisions using AI and ML is accelerating across healthcare systems.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in NGS Informatics

The integration of AI and ML into NGS informatics is revolutionizing genomic data analysis by enabling rapid, accurate, and efficient interpretation of complex datasets. These technologies are embedded into pipelines for variant calling, annotation, and clinical reporting, helping to identify structural rearrangements and polygenic risk scores. Tools like DeepVariant and AlphaFold have improved the interpretation of genomic data in oncology and rare disease diagnostics. Government backing, such as the U.S. National Artificial Intelligence Initiative and the EU's Horizon Europe program, underscores global efforts to integrate AI in biomedical research. AI models also enhance the utility of genomic data when integrated with electronic health records, enabling personalized, evidence-based treatment recommendations. As these models become increasingly sophisticated and validated, they are expected to become central to commercial NGS informatics solutions, supporting the broader implementation of precision medicine.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• PerkinElmer, Inc.
• SOPHiA GENETICS SA
• Precigen, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Eagle Genomics Limited
• BGI Genomics Co., Ltd.

Report Scope:

In this report, the Global Next Generation Sequencing (NGS) Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Product & Services:

• Storage and Computing Tools
• Commercial Data Analysis
• Data Interpretation and Reporting Tools
• Next Generation Sequencing (NGS) Informatics Services
• Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

Global Next Generation Sequencing (NGS) Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
  • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
  • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Products & Services
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Products & Services
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Products & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Products & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Products & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Products & Services
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Products & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
      • 7.3.1.2.4. By Country
  • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Products & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Products & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Products & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Products & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Products & Services
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Products & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Products & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Products & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Products & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Products & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Products & Services
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Products & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Products & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Products & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Products & Services
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Products & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Products & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Products & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Next Generation Sequencing (NGS) Informatics Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd.
• 15.3. PerkinElmer, Inc.
• 15.4. SOPHiA GENETICS SA
• 15.5. Precigen, Inc.
• 15.6. QIAGEN N.V.
• 15.7. Illumina, Inc.
• 15.8. Agilent Technologies, Inc.
• 15.9. Eagle Genomics Limited
• 15.10. BGI Genomics Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer